🖼
Figure 2 — ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatoc
active
paper figure
Created: 2026-04-21T18:29:40
By: paper_figures_tool
Quality:
50%
🔗 External
ID: paper-fig-paper-845a2dc27604-2
Figure 2Figure 2
Knockdown of ARHGEF11 induces cell growth inhibition, cell cycle arrest and cell apoptosis in hepatoma cell lines. ( A ) ARHGEF11 knockdown with two different siRNAs (siARHGEF11-1, siARHGEF11-1) or negative control (siNC) as examined by western blot and qRT-PCR. ( B ) The viability of hepatoma cells detected by CCK8 assay. ( C ) Cell cycle distribution detected by flow cytometry. The representative images (left) and percentage of cell cycle (right) are shown. ( D ) Cell apoptosis detected by flow cytometry. The representative images (left) and relative percentage of apoptotic cells (right) are shown. Data are shown as mean ± SD. * P <0.05, ** P <0.01.
▸Metadata
| pmid | paper-845a2dc27604 |
| caption | Knockdown of ARHGEF11 induces cell growth inhibition, cell cycle arrest and cell apoptosis in hepatoma cell lines. ( A ) ARHGEF11 knockdown with two different siRNAs (siARHGEF11-1, siARHGEF11-1) or n |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC7655160/bin/aging-12-103772-g002.jpg |
| paper_title | ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma through activation of β-catenin pathway. |
| figure_label | Figure 2 |
| figure_number | 2 |
| _schema_version | 1 |
| source_strategy | pmc_api |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.